Physician profile
Robert Cain
NPI 1134669302
$1,687.66
in general payments reported to CMS, 2019-2025
16 companies · $513 in 2025
The $513 reported for 2025 was more than what 89% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $171 · 2022: $71.21 · 2023: $282 · 2024: $650 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,445.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $248.86 | 2024-2025 | Relistor |
| Forte Bio-Pharma LLC | $206.84 | 2023-2024 | Prolate, Nalocet |
| Esperion Therapeutics, INC. | $149.68 | 2021 | |
| Viiv Healthcare Company | $138.57 | 2023-2024 | Rukobia |
| Boston Scientific Corporation | $109.50 | 2023 | Avvigo Guidance System, Opticross |
| Sumitomo Pharma America, INC. | $108.95 | 2024 | Myfembree |
| Amgen INC. | $107.90 | 2025 | Krystexxa |
| Otsuka America Pharmaceutical, INC. | $103.10 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.84 | 2024 | |
| Abbvie INC. | $96.49 | 2023-2025 | |
| Tonix Medicines, INC. | $84.05 | 2025 | |
| Horizon Therapeutics Plc | $53.48 | 2022 | |
| Scilex Pharmaceuticals INC. | $51.33 | 2025 | |
| Abbott Laboratories | $50.45 | 2022-2023 | Dragonfly Opstar |
| Astrazeneca Pharmaceuticals LP | $41.76 | 2021-2023 | Farxiga |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Rehabilitative Sciences, INC | $39.86 | 2024-2025 | Rs 4i Plus Sequential Stimulator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.